The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds

Biomaterials

Volumn 35, Issue 3, 2014, Pages 970-982

  Rajabi Zeleti, Sareh ^a,b   Jalili Firoozinezhad, Sasan ^b   Azarnia, Mahnaz ^a   Khayyatan, Fahimeh ^b   Vahdat, Sadaf ^b   Nikeghbalian, Saman ^c   Khademhosseini, Ali ^d,e,f   Baharvand, Hossein ^b,g   Aghdami, Nasser ^b  

^a KHARAZMI UNIVERSITY   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f HARVARD UNIVERSITY   (United States)

^g UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Cardiac progenitor cells; Decellularization; Macroporous scaffold; Myocardial tissue engineering; Pericardium

Indexed keywords

CARDIAC PROGENITORS; DECELLULARIZATION; MACROPOROUS; MYOCARDIAL TISSUE ENGINEERING; PERICARDIUM;

CARDIOLOGY; DISEASES; HEART; THREE DIMENSIONAL;

SCAFFOLDS (BIOLOGY);

COLLAGEN; STEM CELL ANTIGEN 1; TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COMPRESSION; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR SPACE; HEART STEM CELL; HUMAN; HUMAN CELL; IMPLANTATION; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; RAT; STEM CELL; TENSION; TISSUE ENGINEERING;

CARDIAC PROGENITOR CELLS; DECELLULARIZATION; MACROPOROUS SCAFFOLD; MYOCARDIAL TISSUE ENGINEERING; PERICARDIUM;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; HUMANS; MYOCARDIUM; PERICARDIUM; POROSITY; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84887621564     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.045     Document Type: Article

References (49)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
3. Vunjak-Novakovic G., Lui K.O., Tandon N., Chien K.R. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng 2011, 13:245-267.
4. Tandon V., Zhang B., Radisic M., Murthy S.K. Generation of tissue constructs for cardiovascular regenerative medicine: from cell procurement to scaffold design. Biotechnol Adv 2013, 31:722-735.
5. Karam J.P., Muscari C., Montero-Menei C.N. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials 2012, 33:5683-5695.
6. Callegari A., Bollini S., Iop L., Chiavegato A., Torregrossa G., Pozzobon M., et al. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 2007, 28:5449-5461.
7. Bouten C.V., Dankers P.Y., Driessen-Mol A., Pedron S., Brizard A.M., Baaijens F.P. Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev 2011, 63:221-241.
8. Yang B., Zhang Y., Zhou L., Sun Z., Zheng J., Chen Y., et al. Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. Tissue Eng Part C Methods 2010, 16:1201-1211.
9. DeQuach J.A., Yuan S.H., Goldstein L.S., Christman K.L. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Part A 2011, 17:2583-2592.
10. Bourgine P.E., Pippenger B.E., Todorov A., Tchang L., Martin I. Tissue decellularization by activation of programmed cell death. Biomaterials 2013, 34:6099-6108.
11. Badylak S.F., Weiss D.J., Caplan A., Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012, 379:943-952.
12. Mirmalek-Sani S.H., Orlando G., McQuilling J.P., Pareta R., Mack D.L., Salvatori M., et al. Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials 2013, 34:5488-5495.
13. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
14. Badylak S.F., Taylor D., Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011, 13:27-53.
15. Okada M., Payne T.R., Oshima H., Momoi N., Tobita K., Huard J. Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 2010, 31:7678-7683.
16. Robinson K.A., Li J., Mathison M., Redkar A., Cui J., Chronos N.A., et al. Extracellular matrix scaffold for cardiac repair. Circulation 2005, 112:I135-I143.
17. Seif-Naraghi S.B., Horn D., Schup-Magoffin P.A., Madani M.M., Christman K.L. Patient-to-patient variability in autologous pericardial matrix scaffolds for cardiac repair. JCardiovasc Transl Res 2011, 4:545-556.
18. Parker K.K., Ingber D.E. Extracellular matrix, mechanotransduction and structural hierarchies in heart tissue engineering. Philos Trans R Soc Lond B Biol Sci 2007, 362:1267-1279.
19. Dong X., Wei X., Yi W., Gu C., Kang X., Liu Y., et al. RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering. JMater Sci Mater Med 2009, 20:2327-2336.
20. Wei H.J., Chen S.C., Chang Y., Hwang S.M., Lin W.W., Lai P.H., et al. Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model. Biomaterials 2006, 27:5409-5419.
21. Seif-Naraghi S.B., Salvatore M.A., Schup-Magoffin P.J., Hu D.P., Christman K.L. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A 2010, 16:2017-2027.
22. Ma P.X. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008, 60:184-198.
23. Rouwkema J., Rivron N.C., van Blitterswijk C.A. Vascularization in tissue engineering. Trends Biotechnol 2008, 26:434-441.
24. Wang X., Hu Q., Nakamura Y., Lee J., Zhang G., From A.H., et al. The role of the sca-1+/CD31-cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006, 24:1779-1788.
25. van Vliet P., Roccio M., Smits A.M., van Oorschot A.A., Metz C.H., van Veen T.A., et al. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J 2008, 16:163-169.
26. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
27. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 2005, 102:8966-8971.
28. Rajan N., Habermehl J., Cote M.F., Doillon C.J., Mantovani D. Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat Protoc 2006, 1:2753-2758.
29. Buttafoco L., Engbers-Buijtenhuijs P., Poot A.A., Dijkstra P.J., Daamen W.F., van Kuppevelt T.H., et al. First steps towards tissue engineering of small-diameter blood vessels: preparation of flat scaffolds of collagen and elastin by means of freeze drying. JBiomed Mater Res B Appl Biomater 2006, 77B:357-368.
30. Fischer H., Polikarpov I., Craievich A.F. Average protein density is a molecular-weight-dependent function. Protein Sci 2004, 13:2825-2828.
31. Dyballa N., Metzger S. Fast and sensitive colloidal coomassie G-250 staining for proteins in polyacrylamide gels. JVis Exp 2009, 30.
32. Dornish M., Kaplan D., Skaugrud O. Standards and guidelines for biopolymers in tissue-engineered medical products: ASTM alginate and chitosan standard guides. American Society for Testing and Materials. Ann N Y Acad Sci 2001, 944:388-397.
33. Smits A.M., van Vliet P., Metz C.H., Korfage T., Sluijter J.P., Doevendans P.A., et al. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an invitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 2009, 4:232-243.
34. Pouya A., Satarian L., Kiani S., Javan M., Baharvand H. Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination. PLoS One 2011, 6:e27925.
35. Place E.S., Evans N.D., Stevens M.M. Complexity in biomaterials for tissue engineering. Nat Mater 2009, 8:457-470.
36. Ma D.H., Lai J.Y., Cheng H.Y., Tsai C.C., Yeh L.K. Carbodiimide cross-linked amniotic membranes for cultivation of limbal epithelial cells. Biomaterials 2010, 31:6647-6658.
37. Calderon L., Collin E., Velasco-Bayon D., Murphy M., O'Halloran D., Pandit A. Type II collagen-hyaluronan hydrogel-a step towards a scaffold for intervertebral disc tissue engineering. Eur Cell Mater 2010, 20:134-148.
38. Ji C., Annabi N., Khademhosseini A., Dehghani F. Fabrication of porous chitosan scaffolds for soft tissue engineering using dense gas CO2. Acta Biomater 2011, 7:1653-1664.
39. Annabi N., Mithieux S.M., Zorlutuna P., Camci-Unal G., Weiss A.S., Khademhosseini A. Engineered cell-laden human protein-based elastomer. Biomaterials 2013, 34:5496-5505.
40. Dvir T., Timko B.P., Brigham M.D., Naik S.R., Karajanagi S.S., Levy O., et al. Nanowired three-dimensional cardiac patches. Nat Nanotechnol 2011, 6:720-725.
41. Lee J.M., Boughner D.R. Mechanical properties of human pericardium. Differences in viscoelastic response when compared with canine pericardium. Circ Res 1985, 57:475-481.
42. Mendoza-Novelo B., Avila E.E., Cauich-Rodriguez J.V., Jorge-Herrero E., Rojo F.J., Guinea G.V., et al. Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content. Acta Biomater 2011, 7:1241-1248.
43. Min B.J., Kim Y.J., Choi J.W., Choi S.Y., Kim S.H., Lim H.G. Histologic Characteristics and mechanical properties of bovine pericardium treated with decellularization and alpha-galactosidase: a comparative study. Korean J Thorac Cardiovasc Surg 2012, 45:368-379.
44. Venugopal J.R., Prabhakaran M.P., Mukherjee S., Ravichandran R., Dan K., Ramakrishna S. Biomaterial strategies for alleviation of myocardial infarction. JR Soc Interface 2012, 9:1-19.
45. Wang B., Tedder M.E., Perez C.E., Wang G., de Jongh Curry A.L., To F., et al. Structural and biomechanical characterizations of porcine myocardial extracellular matrix. JMater Sci Mater Med 2012, 23:1835-1847.
46. Mathapati S., Bishi D.K., Guhathakurta S., Cherian K.M., Venugopal J.R., Ramakrishna S., et al. Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering. Mater Sci Eng C Mater Biol Appl 2013, 33:1561-1572.
47. Kraehenbuehl T.P., Langer R., Ferreira L.S. Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods 2011, 8:731-736.
48. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
49. French K.M., Boopathy A.V., DeQuach J.A., Chingozha L., Lu H., Christman K.L., et al. Anaturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior invitro. Acta Biomater 2012, 8:4357-4364.